Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Chiodini

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Folia Endocrinologica|June 1, 1972
[Effects of pharmacological or surgical correction of hypercortisolism on incretion of S.T.H. in Cushing's syndrome]P G Chiodini, A Liuzzi, F Spinelli-Ressi, et al.
Journal of Endocrinological Investigation|June 1, 1985
Medical treatment of pituitary adenomas: effects on tumor growthA Liuzzi, P G Chiodini, D Dallabonzana, et al.
Neuroradiology|January 1, 1982
Macroprolactinomas: CT evaluation of reduction of tumor size after medical treatmentG Scotti, G Scialfa, S Pieralli, et al.
Journal of Endocrinological Investigation|April 1, 1985
Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomasG Verde, G Oppizzi, P G Chiodini, et al.
Folia Endocrinologica|October 1, 1972
[Secretion dynamics of GH in 43 patients with acromegaly]A Liuzzi, P G Chiodini, L Botalla, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1986
Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegalyR Cozzi, D Dallabonzana, G Oppizzi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1980
Homogeneity in the growth hormone-lowering effect of dopamine and somatostatin in acromegalyG Oppizzi, L Botalla, G Verde, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1974
Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administrationA Liuzzi, P G Chiodini, L Botalla, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1975
Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patientsP G Chiodini, A Liuzzi, L Botalla, et al.
Journal of Endocrinological Investigation|April 1, 1985
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegalyD Dallabonzana, A Liuzzi, G Oppizzi, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Folia Endocrinologica|June 1, 1972
[Effects of pharmacological or surgical correction of hypercortisolism on incretion of S.T.H. in Cushing's syndrome]P G Chiodini, A Liuzzi, F Spinelli-Ressi, et al.
Journal of Endocrinological Investigation|June 1, 1985
Medical treatment of pituitary adenomas: effects on tumor growthA Liuzzi, P G Chiodini, D Dallabonzana, et al.
Neuroradiology|January 1, 1982
Macroprolactinomas: CT evaluation of reduction of tumor size after medical treatmentG Scotti, G Scialfa, S Pieralli, et al.
Journal of Endocrinological Investigation|April 1, 1985
Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomasG Verde, G Oppizzi, P G Chiodini, et al.
Folia Endocrinologica|October 1, 1972
[Secretion dynamics of GH in 43 patients with acromegaly]A Liuzzi, P G Chiodini, L Botalla, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1986
Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegalyR Cozzi, D Dallabonzana, G Oppizzi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1980
Homogeneity in the growth hormone-lowering effect of dopamine and somatostatin in acromegalyG Oppizzi, L Botalla, G Verde, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1974
Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administrationA Liuzzi, P G Chiodini, L Botalla, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1975
Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patientsP G Chiodini, A Liuzzi, L Botalla, et al.
Journal of Endocrinological Investigation|April 1, 1985
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegalyD Dallabonzana, A Liuzzi, G Oppizzi, et al.
Pageof 6